Felice, Carla
 Distribuzione geografica
Continente #
NA - Nord America 1.589
EU - Europa 1.224
AS - Asia 875
SA - Sud America 162
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 27
AN - Antartide 1
Totale 3.905
Nazione #
US - Stati Uniti d'America 1.545
DE - Germania 551
SG - Singapore 389
CN - Cina 229
SE - Svezia 144
BR - Brasile 124
FR - Francia 107
UA - Ucraina 95
IT - Italia 89
GB - Regno Unito 72
VN - Vietnam 70
IN - India 46
FI - Finlandia 39
IE - Irlanda 36
ID - Indonesia 31
CA - Canada 29
RU - Federazione Russa 24
BD - Bangladesh 20
JP - Giappone 19
TR - Turchia 17
AR - Argentina 16
PL - Polonia 14
BE - Belgio 12
ES - Italia 9
NL - Olanda 9
HK - Hong Kong 8
EC - Ecuador 7
IR - Iran 6
MX - Messico 6
ZA - Sudafrica 6
AT - Austria 5
JM - Giamaica 5
MA - Marocco 5
VE - Venezuela 5
CI - Costa d'Avorio 4
IQ - Iraq 4
KR - Corea 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BH - Bahrain 3
CO - Colombia 3
PK - Pakistan 3
SA - Arabia Saudita 3
UY - Uruguay 3
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BS - Bahamas 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 3.879
Città #
Chandler 227
Singapore 217
Ashburn 154
San Jose 142
Jacksonville 80
Beijing 51
New York 50
San Mateo 50
Dearborn 47
Ann Arbor 38
Nürnberg 37
Munich 36
Dublin 34
Cattolica 30
Los Angeles 28
Nanjing 28
Jakarta 26
Lauterbourg 26
Wilmington 25
Milan 20
Bremen 17
Hefei 17
Ho Chi Minh City 17
Boston 16
Dallas 16
São Paulo 16
Frankfurt am Main 15
Houston 15
Tokyo 15
Lawrence 14
Brussels 12
Lancaster 11
Toronto 11
Buffalo 10
Hanoi 10
Helsinki 10
Izmir 10
Moscow 10
Turku 10
Warsaw 10
Princeton 9
Seattle 9
Brooklyn 8
Düsseldorf 8
Hong Kong 8
Leawood 8
London 8
Nanchang 8
Rome 8
Detroit 7
Jiaxing 7
Paris 7
Redwood City 7
Haiphong 6
Marseille 6
Montreal 6
Mountain View 6
Philadelphia 6
San Francisco 6
Shanghai 6
Shenyang 6
Stockholm 6
Boardman 5
Changsha 5
Denver 5
Hebei 5
Phoenix 5
The Dalles 5
Woodbridge 5
Abidjan 4
Andover 4
Ardabil 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Calgary 4
Chennai 4
Curitiba 4
Da Nang 4
Dhaka 4
Fairfield 4
Guangzhou 4
Johannesburg 4
Mumbai 4
Orem 4
Redmond 4
Santa Clara 4
Seoul 4
Tianjin 4
Vienna 4
Amsterdam 3
Brasília 3
Casablanca 3
Costa Mesa 3
Duque de Caxias 3
Edinburgh 3
Hangzhou 3
Jinan 3
Kent 3
Kingston 3
Totale 1.913
Nome #
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 230
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 215
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 209
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 199
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 196
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 196
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 192
Ileal Crohn's disease: CEUS determination of activity 183
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 182
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 178
Use of infliximab in particular clinical settings: management based on current evidence. 157
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 154
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 149
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 135
Management of perianal fistulas in Crohn's disease: an up-to-date review 134
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 133
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 132
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 125
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 122
AID in aging and autoimmune diseases 114
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 107
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 104
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 99
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. 93
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 90
Biological therapies for inflammatory bowel disease: controversies and future options 77
Totale 3.905
Categoria #
all - tutte 14.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022210 0 17 4 39 4 3 3 47 7 4 30 52
2022/2023528 71 73 33 103 33 63 17 40 68 2 15 10
2023/2024244 10 50 6 20 3 50 3 33 10 12 24 23
2024/2025457 5 18 49 11 61 15 18 28 52 49 82 69
2025/20261.149 188 37 63 142 200 58 213 49 65 72 31 31
2026/2027147 35 112 0 0 0 0 0 0 0 0 0 0
Totale 3.905